This Government Contract opportunity from New York was posted on September 11, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
MWBE Subcontracting Participation
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Roswell Park Cancer Institute Corp. is seeking subcontracting partnerships with MWBE-certified firms to support technical scopes of work. The primary focus of this opportunity involves specialized services in antibody discovery, expression, or characterization, falling under NAICS code 541715. Interested qualified firms must submit their responses by the deadline of October 23, 2024. This initiative is designed to increase the participation of minority and women-owned business enterprises in high-level technical research and development projects.
General Info
Place of Performance
NY, USASet-Aside
Documents
This scope was carved out of 25-521.
The full solicitation package (14 documents), including the RFP, is on the prime solicitation, not on this scope.
Antibody Discovery Contract Research Organization
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from New York → Roswell Park Cancer Institute Corp.
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
